Actavis to Buy Forest Labs for $25 Billion – Dow Jones Bankruptcy & Debt (registration)
|
Actavis to Buy Forest Labs for $ 25 Billion
Dow Jones Bankruptcy & Debt (registration) Actavis PLC agreed to acquire rival drug maker Forest Laboratories Inc . in a cash-and-stock deal that values Forest at about $ 25 billion. The proposed combination of Dublin-based Actavis and Forest of New York is partly designed to position the … |
